Skip to content
ppharmaranks
Menu

Paromomycin: uses, dosing, side effects & brands

Paromomycin is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Capsule
Sold as
Humatin
Prescription?
Prescription only
Generic available?
Yes

Every paromomycin product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Humatin.

What paromomycin pills look like

Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.

Paromomycin pill imprints
ImprintStrengthColourShape
HP;38250 mgwhite, bluecapsule
HP;38250 mgwhite, bluecapsule

Paromomycin and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

No information is available on the clinical use of paromomycin during breastfeeding. Because paromomycin is poorly absorbed orally, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants.

Full LactMed record for paromomycin: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised September 15, 2023. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about paromomycin

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 30 reports naming paromomycin, and the FDA flagged 53% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • diarrhoea8 reports
  • blood cholesterol increased4 reports
  • cholestasis2 reports
  • deafness2 reports
  • dizziness2 reports
  • nausea2 reports
  • vomiting2 reports
  • abdominal pain1 reports

Read these as a signal, not a rate. A report does not mean paromomycin caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved July 25, 2026.

Related calculators

Frequently asked questions

Can you take paromomycin with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run paromomycin against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does paromomycin come in?

Across the brands we track, paromomycin is currently marketed as capsule, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic paromomycin?

Yes. Our catalog lists 1 generic paromomycin product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Cite this page
APA
pharmaranks. (2026, July 24). Paromomycin: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/paromomycin
MLA
“Paromomycin: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/paromomycin.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for paromomycin on DailyMed (NIH) ↗.